Columbus innovation on overdrive in Covid-19 response
On Jan. 19, a 35-year-old man in the state of Washington visited an urgent care with a cough and fever. He had just returned to the United States from visiting family in Wuhan, China, the epicenter of the COVID-19 global pandemic.
Nearly 2,500 miles away, scientists inside Columbus’ premier research institution realized they had a problem. Though the virus had yet to spread across the U.S. and become the singular focus of the 24-hour news cycle, the people at Battelle, which plays a key role in the global scientific community, were keenly aware of the outbreak happening in China. A decision was made quickly. Battelle would use its expertise in infectious disease to ramp up development of highly complex tests called assays to support the creation of a vaccine and therapies to treat COVID-19. The research giant’s work, however, didn’t stop there.
Click here to read the complete story.
Story excerpt provided by Columbus CEO.
Written by Laura Newpoff.
Originally published May 2, 2020.
Leave a Reply